Introduction: FOXO4-DRI peptide enables selective apoptosis of senescent cells, supports metabolic scientific tests, and ensures security in study, improving reproducibility and advancing growing old and oncology investigations. day-to-day laboratory workflows normally expose gaps exactly where current compounds are unsuccessful to handle cell sen